NanoVelos Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $1.12M

  • Investors
  • 7

NanoVelos General Information

Description

Developer of cancer treatment drugs designed to create a method of coating active substances with nano-particles of polysaccharides. The company's technology transforms generics to super-generics via a dextran-based nano-particle delivery system and exhibits dramatically improved tumor targeting, enabling medical professionals to enhance therapeutic efficacy while minimizing adverse effects on healthy tissues.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Corporate Office
  • Rakowiecka 36
  • Room 260
  • Warsaw, 02-532
  • Poland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NanoVelos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 16-Dec-2017 $1.12M 00.000 00.000 Completed Generating Revenue
3. Early Stage VC 01-Jul-2015 Completed Generating Revenue
2. Grant $347K Completed Startup
1. Early Stage VC 10-Apr-2013 Completed Startup
To view NanoVelos’s complete valuation and funding history, request access »

NanoVelos Patents

NanoVelos Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3761955-A1 Anthracycline encapsulated with polysaccharide for use in the treatment of tumours Pending 06-Mar-2018 0000000000
US-20210052616-A1 Anthracycline encapsulated with a polysaccharide for use in the treatment of tumours Inactive 06-Mar-2018 00000000000
ES-2780387-T3 Procedure for the preparation of polysaccharide nanoparticles Active 14-Mar-2012 000000000
EP-2825563-A1 Process for the preparation of polysaccharide nanoparticles Active 14-Mar-2012 0000000000
EP-2825563-B1 Process for the preparation of polysaccharide nanoparticles Active 14-Mar-2012 A61K9/5192 0
To view NanoVelos’s complete patent history, request access »

NanoVelos Executive Team (8)

Name Title Board Seat Contact Info
Anna Redwan Chief Executive Officer & Chief Operating Officer
Tomasz Ciach Ph.D Co-Founder & Board Member
Wioletta Kosnik Board Member & Project Manager Preclinical Researchnager
You’re viewing 3 of 8 executive team members. Get the full list »

NanoVelos Board Members (8)

Name Representing Role Since
Adam Kiciak Ph.D Self Board Member 000 0000
Agata Stefanek Ph.D NanoVelos Board Member 000 0000
Marek Borzestowski Giza Polish Ventures President of the Supervisory Board 000 0000
Piotr Pietrzak Self Member of the Supervisory Board 000 0000
Tomasz Ciach Ph.D NanoVelos Co-Founder & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

NanoVelos Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NanoVelos Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ZernikeMeta Ventures Venture Capital Minority 000 0000 000000 0
Michal Solowow Angel (individual) Minority 000 0000 000000 0
PFR Ventures Limited Partner Minority 000 0000 000000 0
Giza Polish Ventures Venture Capital Minority 000 0000 000000 0
Krajowy Fundusz Kapitałowy Fund of Funds Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

NanoVelos FAQs

  • When was NanoVelos founded?

    NanoVelos was founded in 2013.

  • Who is the founder of NanoVelos?

    Iga Wasiak Ph.D and Tomasz Ciach Ph.D are the founders of NanoVelos.

  • Who is the CEO of NanoVelos?

    Anna Redwan is the CEO of NanoVelos.

  • Where is NanoVelos headquartered?

    NanoVelos is headquartered in Warsaw, Poland.

  • What is the size of NanoVelos?

    NanoVelos has 6 total employees.

  • What industry is NanoVelos in?

    NanoVelos’s primary industry is Drug Delivery.

  • Is NanoVelos a private or public company?

    NanoVelos is a Private company.

  • What is the current valuation of NanoVelos?

    The current valuation of NanoVelos is 00.000.

  • What is NanoVelos’s current revenue?

    The current revenue for NanoVelos is 00000.

  • How much funding has NanoVelos raised over time?

    NanoVelos has raised $1.12M.

  • Who are NanoVelos’s investors?

    ZernikeMeta Ventures, Michal Solowow, PFR Ventures, Giza Polish Ventures, and Krajowy Fundusz Kapitałowy are 5 of 7 investors who have invested in NanoVelos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »